Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy

Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy

Low skeletal muscle mass (SMM) is associated with toxicities and decreased survival in head and neck cancer (HNC). Chemoradiotherapy (CRT) may exaggerate loss of SMM. We investigated the changes in SMM, their predictors, and prognostic impact of SMM in patients treated with CRT between 2012 and 2018...

Full description

Bibliographic Details
Main Authors: Najiba Chargi, Inge Wegner, Navid Markazi, Ernst Smid, Pim de Jong, Lot Devriese, Remco de Bree
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Clinical Medicine
Subjects:
sarcopenia
head and neck cancer
body composition
skeletal muscle mass
muscle wasting
chemoradiotherapy
Online Access:https://www.mdpi.com/2077-0383/10/8/1762

Internet

https://www.mdpi.com/2077-0383/10/8/1762

Similar Items